1120278

Phillip M. Pierorazio, MD — FEI 3016053302

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 14, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Baltimore, MD (United States)

Additional Details

Clinical Investigator (CI)